Nomura Asset Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,768
Closed -$491K 1525
2024
Q1
$704K Hold
18,768
﹤0.01% 811
2023
Q4
$1.05M Sell
18,768
-3,509
-16% -$153K ﹤0.01% 791
2023
Q3
$919K Hold
22,277
﹤0.01% 804
2023
Q2
$1.24M Hold
22,277
0.01% 782
2023
Q1
$1.24M Hold
22,277
0.01% 780
2022
Q4
$812K Hold
22,277
﹤0.01% 826
2022
Q3
$634K Hold
22,277
﹤0.01% 837
2022
Q2
$1.01M Sell
22,277
-15,480
-41% -$803K 0.01% 813
2022
Q1
$2.87M Sell
37,757
-6,272
-14% -$549K 0.02% 645
2021
Q4
$6.56M Buy
44,029
+29,949
+213% +$4.59M 0.03% 433
2021
Q3
$2.05M Buy
14,080
+210
+2% +$36.1K 0.01% 702
2021
Q2
$2.72M Buy
13,870
+3,000
+28% +$543K 0.02% 650
2021
Q1
$1.97M Buy
10,870
+180
+2% +$31.1K 0.01% 723
2020
Q4
$1.51M Buy
+10,690
New +$1.55M 0.01% 759

Other funds holding TXG

Nomura Asset Management's TXG Position: Q2 2024 in Review

Nomura Asset Management sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 18,768 shares — an estimated $491K sold.

Nomura Asset Management first reported a position in TXG in Q4 2020 and held it in 14 quarters. The position peaked at $6.56M in Q4 2021. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Nomura Asset Management reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Nomura Asset Management sold 18,768 10x Genomics shares in Q2 2024, an estimated $491K.
  • Nomura Asset Management first reported a position in 10x Genomics in Q4 2020 and held it in 14 quarters.
  • Nomura Asset Management's 10x Genomics position peaked at $6.56M in Q4 2021.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Nomura Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.